Literature DB >> 9287970

Chromosomal alterations in ulcerative colitis-related neoplastic progression.

R F Willenbucher1, S J Zelman, L D Ferrell, D H Moore, F M Waldman.   

Abstract

BACKGROUND & AIMS: It is unclear whether genomic derangement precedes the histological development of dysplasia in ulcerative colitis (UC)-related neoplastic progression. The primary aim of this study was to determine if chromosomal alterations occur early in the progression pathway of UC-related neoplasia.
METHODS: Fluorescence in situ hybridization (FISH) was performed on nuclei dissociated from sites of cancer, dysplasia, and UC-involved nondysplastic epithelium in five UC-related cancer colectomy specimens using a panel of pericentromeric probes. Comparative genomic hybridization (CGH) was used to detect clonal chromosomal losses and gains in DNA extracted from these sites.
RESULTS: FISH analysis revealed significant and often dramatic alterations in chromosome copy number compared with controls in all biopsy specimens of cancer, dysplasia, and nondysplastic UC-involved epithelium. Clonal chromosomal losses and gains were detected by CGH in all but one analyzed site of dysplasia and cancer and in two of the five nondysplastic sites. FISH and CGH frequently detected the relative loss of chromosome 18.
CONCLUSIONS: Chromosomal alterations may occur early in UC-related neoplastic progression and seem to precede the histological development of dysplasia. Relative loss of 18q may be important in the progression of UC-related neoplasia. The detection of chromosomal alterations as an intermediate end point may prove useful in identifying patients at high risk for the development of colorectal cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9287970     DOI: 10.1016/s0016-5085(97)70173-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

Review 1.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 2.  Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.

Authors:  Sigrun Thorsteinsdottir; Thorkell Gudjonsson; Ole Haagen Nielsen; Ben Vainer; Jakob Benedict Seidelin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

Review 3.  Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

Authors:  Eun Ran Kim; Dong Kyung Chang
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.

Authors:  Mary P Bronner; Jacintha N O'Sullivan; Peter S Rabinovitch; David A Crispin; Lu Chen; Mary J Emond; Cyrus E Rubin; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

5.  Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.

Authors:  Mary P Bronner; Marek Skacel; David A Crispin; Peter D Hoff; Mary J Emond; Lisa A Lai; Raymond R Tubbs; Jacintha N O'Sullivan; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

Review 6.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

7.  Proteins That Underlie Neoplastic Progression of Ulcerative Colitis.

Authors:  Teresa A Brentnall; Sheng Pan; Mary P Bronner; David A Crispin; Hamid Mirzaei; Kelly Cooke; Yasuko Tamura; Tatiana Nikolskaya; Lellean Jebailey; David R Goodlett; Martin McIntosh; Ruedi Aebersold; Peter S Rabinovitch; Ru Chen
Journal:  Proteomics Clin Appl       Date:  2009-09-14       Impact factor: 3.494

8.  Riboflavin depletion of intestinal cells in vitro leads to impaired energy generation and enhanced oxidative stress.

Authors:  Eun-Sook Lee; Bernard M Corfe; Hilary J Powers
Journal:  Eur J Nutr       Date:  2012-11-06       Impact factor: 5.614

Review 9.  Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.

Authors:  Parambir S Dulai; William J Sandborn; Samir Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-27

10.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.